Position in ARGX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,052,091
+$234,211 QoQ
Shares Held
1,134
+1.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
#243
of 504 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Future Fund LLC holds $27,055,231 across 6 Biotechnology names. ARGX ranks #6 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HALO |
Halozyme Therapeutics, Inc.
|
142,007 | $11,114,887 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
|
71,362 | $5,658,292 | |
| 3 | LGND |
Ligand Pharmaceuticals Inc
|
14,704 | $4,647,787 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,037 | $2,502,029 | |
| 5 | ADMA |
Adma Biologics, Inc.
|
248,524 | $2,080,145 | |
| 6 | ARGX |
Argenx SE
This page
|
1,134 | $1,052,091 |
All Filings in ARGX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,052,091 | 1,134 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $817,880 | 1,120 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $935,977 | 1,113 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $929,325 | 1,260 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $504,366 | 915 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $435,612 | 736 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||